BSE filing, NSE: VAML. Summary written from the filing by ALFA Finder's alert engine.
Vedanta Aluminium Metal Ltd: key numbers
- Share price
- ₹359.00
- Market cap
- ₹1,40,383 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.04 Cr
- Promoter holding
- 56.38%+0.00% QoQ
- FII holding
- 11.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vedanta Aluminium Metal Ltd
All →Vedanta Aluminium Metal Earnings Call Transcript: Key Takeaways
Vedanta Aluminium delivered record production and EBITDA growth despite softening LME prices.
Vedanta Aluminium Metal Debt & Borrowing
Vedanta Aluminium Metal Ltd filed a Reg 54 security cover certificate for its ₹6,089 Cr secured NCDs and a Reg 52(7) NIL utilisation statement for Q2 FY27.
Vedanta Aluminium Metal Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹22,066 Cr (+41% YoY), EBITDA ₹10,192 Cr (+83% YoY), PAT ₹6,187 Cr (+105% YoY); record 649 KT aluminium output.
Vedanta Aluminium Metal Q2 FY27 Results: Net Profit ₹6,187 Cr, Up 105.4% YoY
Vedanta Aluminium Metal Ltd reported revenue from operations of ₹22,324 Cr (+40.0% YoY) and net profit of ₹6,187 Cr (+105.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6,187 Cr · +105.4% YoY
Vedanta Aluminium Metal Other Announcement
Vedanta Aluminium Metal Ltd filed its Regulation 27 and 51 integrated governance filing for the quarter ended September 30, 2026. The filing covers the Corporate Governance Report and investor complaint status.
Vedanta Aluminium Metal Board Meeting Date
Vedanta Aluminium will hold a board meeting on October 28, 2026, to consider its quarterly financial results. An earnings conference call is scheduled thereafter.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date